News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Irene Ghobrial: Deeper response predicts better outcomes in high-risk-smoldering-myeloma
Irene Ghobrial/bloodcancerstoday.com
Jan 21, 2025, 17:03

Irene Ghobrial: Deeper response predicts better outcomes in high-risk-smoldering-myeloma

Irene Ghobrial, Professor Of Medicine at Dana-Farber Cancer Institute, shared a post on LinkedIn about a recent paper by her and colleagues published in Nature Communications:

“Response matters in high-risk smoldering myeloma. Our study also demonstrates that whole genome sequencing and immune cell sequencing can predict response to therapy.”

“Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial”

Authors: Omar Nadeem, Michelle Aranha, Robert Redd, Romanos Sklavenitis-Pistofidis, Irene Ghobrial et al.

Irene Ghobrial: Deeper response predicts better outcomes in high-risk-smoldering-myeloma

cancer Irene Ghobrial Michelle Aranha Omar Nadeem OncoDaily Oncology Robert Redd Romanos Sklavenitis-Pistofidis smoldering myeloma
Special Coverage
Blog
Apr 1, 2025, 17:18
Exploring AI’s Role in Cancer Care at ESTRO 2025
Blog
Apr 1, 2025, 17:01
The Power Over Cancer Gathering at Springhill Church - UF Health Cancer Center
Blog
Apr 1, 2025, 16:40
Estelamari Rodriguez: Speaking at the Latino Medical Student Association regional conference
Blog
Apr 1, 2025, 16:32
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers
Blog
Apr 1, 2025, 16:21
Azra Raza featured in SPCC's fifth episode of the "Behind Every Drug There’s a Story" series
Blog
Apr 1, 2025, 16:18
The EBMT 2025 Election Results
Career
Apr 1, 2025, 16:02
Jay Bhattacharya begins his tenure as the 18th NIH Director - National Institutes of Health
Positive
Apr 1, 2025, 15:45
Mark Lanasa: Positive CHMP opinion for BeOne Medicines' first-line immunotherapy in ES-SCLC
Blog
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia
Blog
Apr 1, 2025, 15:04
Call for Papers: AI in Immune-Related Adverse Events (irAEs) - AI in Precision Oncology
Career
Apr 1, 2025, 14:57
Sharon Burk completes PhD with groundbreaking research - Sbarro Health Research Organization
Blog
Apr 1, 2025, 14:35
Douglas Flora: The messy truth behind healthcare's coming AI adoption